Clinitech Laboratory Ltd - 544220 - General Update Under Reg 30 Of SEBI (LODR) Regulations For Change In Market Maker
Clinitech Laboratory Limited's Board approved a change in market maker from SVCM Securities Private Limited to Kalpalabdhi Financials Private Limited. The change is effective from April 10, 2026, following SVCM's internal restructuring and involves a tripartite agreement with Inventure Merchant Banker Services.
Apr 09 2026 15:04:00
Clinitech Laboratory Ltd - 544220 - General Update W.R.T Receipt Of Letter From Promoter Under Reg 31(4) Of SEBI (SAST) Regulations For The Year Ended March 31, 2026
Clinitech Laboratory's promoter group declared no encumbrance on shares for the financial year ended March 31, 2026. Promoter Jagdish Umakant Nayak also acquired 9,600 additional shares on March 30, 2026, enhancing promoter holding.
Apr 06 2026 16:04:00
Clinitech Laboratory Ltd - 544220 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Clinitech Laboratory Promoter Jagdish Umakant Nayak acquired 9,600 equity shares on March 30, 2026. This open market transaction increased his shareholding by 0.42% to 64.62%.
Mar 30 2026 17:03:00
Clinitech Laboratory Ltd - 544220 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Clinitech Laboratory's promoter group member, Siddhesh Anant Nayak, acquired 2,400 equity shares on March 27, 2026. This open market purchase increased the promoter group's holding by 0.05% to 64.20%.
Mar 30 2026 12:03:00
Clinitech Laboratory Ltd - 544220 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Clinitech Laboratory's promoter Jagdish Umakant Nayak acquired 1,200 equity shares on March 25, 2026, through open market. This transaction increased the promoter's and PAC's total shareholding to 64.15% from 64.10%.
Mar 28 2026 16:03:00
Clinitech Laboratory Ltd - 544220 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Clinitech Laboratory's promoter group, led by Siddhesh Anant Nayak, acquired 2,400 equity shares through the open market on March 24, 2026. This transaction increased their total shareholding from 63.99% to 64.10%.
Mar 27 2026 11:03:00
Read More
